Information for Industry

Guidance on the regulatory processes for suppliers in New Zealand of medicines and medical devices.

Approval Process

Date	Type	Title
15/9/2021	COVID-19	Adverse events following immunisation with COVID-19 vaccines: Safety Report #26 – 28 August 2021
8/9/2021	COVID-19	Adverse events following immunisation with COVID-19 vaccines: Safety Report #25 – 21 August 2021
6/9/2021	Committees	Agenda for the 67th Medicines Classification Committee meeting
2/9/2021	Publications	Prescriber Update Vol. 42 No. 3 – September 2021
1/9/2021	COVID-19	Adverse events following immunisation with COVID-19 vaccines: Safety Report #24 – 14 August 2021
30/8/2021	Committees	Agenda for the 187th Medicines Adverse Reactions Committee meeting - 9 September 2021
25/8/2021	COVID-19	Adverse events following immunisation with COVID-19 vaccines: Safety Report #23 – 7 August 2021
18/8/2021	COVID-19	Adverse events following immunisation with COVID-19 vaccines: Safety Report #22 – 31 July 2021
12/8/2021	Monitoring Communication	Dihydrocodeine: review of risks and benefits
11/8/2021	COVID-19	Adverse events following immunisation with COVID-19 vaccines: Safety Report #21 – 24 July 2021
9/8/2021	Committees	Medicines Classification Committee - Dates and Deadlines
9/8/2021	Committees	Minutes of the 66th meeting of the Medicines Classification Committee - 11 May 2021
4/8/2021	COVID-19	Adverse events following immunisation with COVID-19 vaccines: Safety Report #20 – 17 July 2021
28/7/2021	COVID-19	Adverse events following immunisation with COVID-19 vaccines: Safety Report #19 – 10 July 2021

If you have a query that is not answered by the information in this section please contact us at askmedsafe@health.govt.nz